High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.

MLA

Anderson, Peter M., et al. “High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients with Osteosarcoma and Bone Metastases.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 20, no. 1, Jan. 2002, pp. 189–96. EBSCOhost, https://doi.org/10.1200/JCO.2002.20.1.189.

APA

Anderson, P. M., Wiseman, G. A., Dispenzieri, A., Arndt, C. A. S., Hartmann, L. C., Smithson, W. A., Mullan, B. P., & Bruland, O. S. (2002). High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 20(1), 189–196. https://doi.org/10.1200/JCO.2002.20.1.189

Chicago

Anderson, Peter M, Gregory A Wiseman, Angela Dispenzieri, Carola A S Arndt, Lynn C Hartmann, William A Smithson, Brian P Mullan, and Oyvind S Bruland. 2002. “High-Dose Samarium-153 Ethylene Diamine Tetramethylene Phosphonate: Low Toxicity of Skeletal Irradiation in Patients with Osteosarcoma and Bone Metastases.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 20 (1): 189–96. doi:10.1200/JCO.2002.20.1.189.